Thomas Jefferson University (Philadelphia, Pennsylvania) announced plans to offer three graduate certificates in cannabis science at their Institute of Emerging Health Professions.
According to the university, their expert faculty members developed the three academic graduate certificates for healthcare and cannabis industry professionals to learn the current cannabinoid therapies and their health effects. They also reportedly partnered with the Center for Forensic Science Research and Education for their leading expertise in toxicological analysis to deliver an unparalleled learning experience.
The three certificates include:
The university also offers non-degree options for the two courses titled “Cultural History, Regulation” and “Policy of Cannabis and Cannabinoid Research Design.” For more information, visit www.jefferson.edu/CannabisCertificates.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Khan
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.